Progress in research of vaccination for patients with cancer / 中华流行病学杂志
Chinese Journal of Epidemiology
; (12): 98-101, 2018.
Article
en Zh
| WPRIM
| ID: wpr-737925
Biblioteca responsable:
WPRO
ABSTRACT
Due to the tumor malignancy or immunosuppressive treatment, patients with cancer in general are more susceptible to vaccine-preventable infections. The types, timing, dose of vaccination or even the immunization program for them may differ from those for the normal persons. At present, it is recommended to use inactivated vaccines for patients with cancer rather than attenuated live vaccines, Vaccinations should be avoided during immunosuppressive therapy; patients with cancer should receive double dosage of hepatitis B vaccines and two doses of inactivated influenza vaccines yearly. This paper summarizes the progress in clinical trials of vaccination for cancer patients in foreign countries, and provide reference for the development and implementation of vaccination strategy for cancer patients in China.
Palabras clave
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Investigación
/
China
/
Vacunación
/
Neoplasias
Límite:
Humans
País/Región como asunto:
Asia
Idioma:
Zh
Revista:
Chinese Journal of Epidemiology
Año:
2018
Tipo del documento:
Article